Výsledky vyhledávání

Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106

Autor: Neil J. Grossman, W A Bleyer, Gregory H. Reaman, A R Ablin, Louis Novak, Allan F. Pyesmany, Paul S. Gaynon, J Z Finklestein, V C Albo, Peter G. Steinherz

Publikováno v: Journal of Clinical Oncology. 11:2234-2242

PURPOSE On past Childrens Cancer Group (CCG) trials, children with acute lymphoblastic leukemia and unfavorable presenting features had obtained an event-free survival (EFS) rate of no better than 50%. Following promising pilot experience, this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1987437a19ce538e67ad1ebfc3c12a4e
https://doi.org/10.1200/jco.1993.11.11.2234

Zobrazit plný text záznamu

Delayed resection in the management of non-orbital rhabdomyosarcoma of the head and neck in childhood

Autor: J, Blatt, C, Snyderman, M R, Wollman, J, Mirro, I P, Janecka, V C, Albo, M, Deutsch, J E, Janosky, E S, Wiener

Publikováno v: Medical and pediatric oncology. 28(4)

This retrospective study was undertaken to evaluate the effect of delayed resection on outcome of head and neck rms in a single institution which has experience in cranial base surgery. Since 1988, patients with primary non-orbital rms of the head an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d929c06c224fd25a4525fc01635d1764
https://pubmed.ncbi.nlm.nih.gov/9078331

Zobrazit plný text záznamu

Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group

Autor: P S, Gaynon, P G, Steinherz, W A, Bleyer, A R, Ablin, V C, Albo, J Z, Finklestein, N J, Grossman, P S, Littman, L T, Novak, A F, Pyesmany

Publikováno v: Lancet (London, England). 2(8617)

229 children with acute lymphoblastic leukaemia (ALL) and with clinical and laboratory features associated with a high risk of treatment failure entered a randomised study of three treatment regimens. Before 1981, such patients had a 3-year event-fre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a547fce8254adee2da07cb472b3e4ac9
https://pubmed.ncbi.nlm.nih.gov/2902379

Zobrazit plný text záznamu

Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children

Autor: A L, Kovatch, E R, Wald, V C, Albo, W, Prin, S J, Orlando, M R, Wollman, C K, Phebus, E D, Shapiro

Publikováno v: Pediatrics. 76(5)

We conducted a randomized, double-blind, placebo-controlled study to evaluate the efficacy of oral trimethoprim/sulfamethoxazole (TMP/SMX) in the prevention of bacterial infections in children with cancer. Sixty-three patients with acute leukemia wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1d46b5f22c6caefbf2da3d4dbadbef5d
https://pubmed.ncbi.nlm.nih.gov/3903647

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání